Table 2: Clinical presentation and location of occlusion
PMT (n = 28) | CDT (n = 89) | p value | |
|---|---|---|---|
DURATION OF SYMPTOMS | |||
Less than 24 h | 5 (17.9%) | 13 (14.6%) | 0.338 |
1 to 7 days | 12 (42.9%) | 52 (58.4%) | |
8 to 14 days | 11 (39.25) | 24 (27%) | |
RUTHERFORD CLASSIFICATION | |||
I and IIA | 23 (82.1%) | 56 (62.9%) | 0.058 |
IIB | 5 (17.9%) | 33 (37.1%) | |
OCCLUSION | |||
Thrombosed at stent | 16 (57.1%) | 12 (13.4%) | |
Thrombosed at bypass | 4 (14.3%) | 24 (27%) | |
Thrombosed at native vessel | 8 (28.6%) | 53 (59.6%) | |
OCCLUDED | |||
Iliac | 1 (3.6%) | 0 (0%) | |
Iliofemoral | 1 (3.6%) | 5 (5.6%) | |
Femoral, popliteal | 15 (53.6%) | 30 (33.7%) | |
Femorocrural | 7 (25%) | 50 (57.3%) | |
Crural & pedal | 4 (14.3%) | 3 (3.4%) | |